Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Van den Wyngaert

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2015
Prediction vs. Prognostication and Guarantee-Time Bias: Steering Clear of the Pitfalls of Interpreting Observational DataTim Van den Wyngaert
The Journal of Evidence-Based Dental Practice|October 31, 2007
Osteonecrosis of the jaw (ONJ) might explain the increased oral surgery risk in cancer patients treated with bisphosphonatesTim Van den Wyngaert
The Journal of Evidence-Based Dental Practice|November 27, 2012
Topical honey application to reduce radiation-induced oral mucositis: a therapy too sweet to ignore?Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 19, 2019
Radionuclide imaging and therapy of bone metastases in the era of targeted therapyTim Van den Wyngaert, Frédéric Paycha
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2016
Reply to: Starck et alTim Van den Wyngaert, Frédéric Paycha
Plos One|April 12, 2019
Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerabilityPaul Germonpré, Tim Van den Wyngaert
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Letter to the editor about 360 CZT bone imagingRichard Graham, Tim Van Den Wyngaert
Seminars in Musculoskeletal Radiology|March 12, 2026
Nuclear Medicine Imaging for Spinal Pain in the Pre- and Postoperative SettingAster Marin, Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019
The changing role of radium-223 in metastatic castrate-resistant prostate cancer: has the EMA missed the mark with revising the label?Tim Van den Wyngaert, Bertrand Tombal
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 15, 2022
Local treatment of synovitisTim VAN DEN Wyngaert, Willm U Kampen
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2015
Prediction vs. Prognostication and Guarantee-Time Bias: Steering Clear of the Pitfalls of Interpreting Observational DataTim Van den Wyngaert
The Journal of Evidence-Based Dental Practice|October 31, 2007
Osteonecrosis of the jaw (ONJ) might explain the increased oral surgery risk in cancer patients treated with bisphosphonatesTim Van den Wyngaert
The Journal of Evidence-Based Dental Practice|November 27, 2012
Topical honey application to reduce radiation-induced oral mucositis: a therapy too sweet to ignore?Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 19, 2019
Radionuclide imaging and therapy of bone metastases in the era of targeted therapyTim Van den Wyngaert, Frédéric Paycha
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2016
Reply to: Starck et alTim Van den Wyngaert, Frédéric Paycha
Plos One|April 12, 2019
Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerabilityPaul Germonpré, Tim Van den Wyngaert
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Letter to the editor about 360 CZT bone imagingRichard Graham, Tim Van Den Wyngaert
Seminars in Musculoskeletal Radiology|March 12, 2026
Nuclear Medicine Imaging for Spinal Pain in the Pre- and Postoperative SettingAster Marin, Tim Van den Wyngaert
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 13, 2019
The changing role of radium-223 in metastatic castrate-resistant prostate cancer: has the EMA missed the mark with revising the label?Tim Van den Wyngaert, Bertrand Tombal
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 15, 2022
Local treatment of synovitisTim VAN DEN Wyngaert, Willm U Kampen
Pageof 10